1[1]Ambrosini G, Adida C. A novel anti-apoptosis gene, surivin, expressed in cancer and 1ymphoma[J].Nat Med,1997,3(8):917～921.
2[2]Muchmore SW, Chen J, Jakob C,et al.Crystal structure and mutagenic analysis of the inhibitor of apoptosis protein survivin[J].Mol Cell,2000 ,6(1):173～182.
3[3]Mahotka C,Wenzel M,Springer E,et al.Survivin-delta Ex3 and sur vivin-2B:two novel splice variants of the apoptosis inhibitors survivin with different antiapoptotic properties[J].Cancer Res,1999,59(24):6097～6102.
4[4]Tamm I,Wang Y,Sausville E,et al.IAP-family protein survivin in hibits caspase activity and apoptosis induced by Fas(CD95),Bax,caspases,and anticancer drugs[J].Cancer Res,1998,58(23):5315～5320.
5[5]Suzuki A, Ito T,Kawano H,et al.survivin initiates procaspase 3 /P21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death[J].Oncogene,2000,19(10):1346～1353.
6[6]Li F,Ambrosini G, Chu EY,et al.Control of apoptosis and mitotic spindle checkpoint by Survivn[J].Nature,1998,369(6711):580～584.
7[7]Li F,Altieri DC.Transcriptional analysis of human survivin gene expression[J].Biochem.J,1999,344:305～311.
8[8]Cohen C,Lohmann CM,Cotsonis G,et al.Survivin expression in ova rian carcinoma: correlation with apoptotic markers and prognosis[J].Mod Patho l,2003,16(6):574～583.
9[9]Takai N,Miyazaki T, Nishida M,et al.Exporession of survivin is associated with malignant potential in epithelial ovarian carcinoma[J].Int J Mol Med,2002,10(2):211～216.
10[10]Sui L,Dong Y,Ohno M,et al. Survivin expression and its correl ation with cell proliferation and prognosis in epithelial ovarian tumors[J].Int J Oncol,2002,21(2):315～320.
2Lehner R,Enomoto T,McGregar GA,et al.Correlation of survivin mRNA detection with hislological diagnosis in normal endometrium and endometrial carcinoma[J].Acta Obstet Gynecol Scand,2002,81(2):162-167.
3Tarkowski R,W,Wojcierowski J,Polak G,el a1.Expression of t he survivin gene in normal and hyperplastie endomet rium[J].Ginekol Pol,2000,71(9):1226.
4Taylor R N,Lebovie D J,HomungD.et al.Endocrine and paracrine regulation of endometrial angiogenesis[J].Ann N Y Acad Sci,2001,943:109-121.
5Takai N,Miyazaki T,Nishida M,et al.Survivin expression correlates with clinical stage,histological grade,invasive behavior and sur-vival rate in endometrial carcinoma[J].Cancer Lett,2002,184(1):105-116.
6乐杰.妇产科学[M]5版[M].北京:人民卫生出版社,2001.129.
7Rohayem J, Diestelkoetter P, Weigle B, et al. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients[J]. Cancer Res,2000,60(7):1815～1817.
8Suzuki A, Ito T , Kawano H, et al. Survivin initiates procaspase3/p21 complex formation as a result of interaction with CDK4 to resist Fas-mediated cell death [J] .Oncogene, 2000, 19(10): 1346～1353.
9Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. [J] Nature,1998,396(6711):580～584.
10Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate [J]. J Biol Chem, 1998,273(22): 13375～13378.
